LCP NPs loaded with the modified tumor-specific BRAF-mutant peptide were effectively activate advanced BRAF-specific immune response as well as a significant increase in IFN- production
In recent years, GLP-1 receptor agonist injections such as semaglutide (Wegovy) or tirzepatide (Zepbound) have dominated the news as a promising medical therapy for weight loss
Designed for adults with a BMI of 30 or higher, or 27 and higher with weight-related conditions, Wegovy offers significant weight reduction, with clinical trials showing a 15% average weight loss over 68 weeks
Throughout testing and research, medical safety was a priority, and we encourage you to speak with your doctor or other health professional before using any meal plan for weight loss
Saper RB, Eisenberg DM, Phillips RS (2004) Common dietary supplements for weight loss